» Articles » PMID: 29424088

A Review of Measures Used in the Screening, Assessment and Diagnosis of Dementia in People with an Intellectual Disability

Overview
Date 2018 Feb 10
PMID 29424088
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The increasing number of individuals with an intellectual disability who are at risk of developing dementia highlights the need to use measures with strong psychometric properties as part of the screening, assessment and diagnostic process.

Method: Searches were made of clinical and good practice guidelines and English language journal articles sourced from Proquest, Web of Science and Scopus databases (up to July 2017) for tools which were designed or adapted for the purpose of helping to diagnose dementia in people with intellectual disability.

Results: Based on a detailed review of 81 articles and guidelines, the present authors identified 22 relevant tools (12 cognitive, 10 behaviour). These were reviewed in terms of their psychometric properties.

Conclusions: A number of tools were found to be available for use with people with intellectual disability; however, few were specifically standardized for this purpose which also had comprehensive information about reliability and validity.

Citing Articles

Dementia in People with Severe/Profound Intellectual (And Multiple) Disabilities, and Its Natural History.

Wissing M, Hobbelen J, De Deyn P, Waninge A, Dekker A J Ment Health Res Intellect Disabil. 2024; 17(1):1-28.

PMID: 39691734 PMC: 11649213. DOI: 10.1080/19315864.2023.2240734.


Dementia in Rare Genetic Neurodevelopmental Disorders: A Systematic Literature Review.

Kwetsie H, van Schaijk M, van der Lee S, Maes-Festen D, Ten Hoopen L, van Haelst M Neurology. 2024; 102(11):e209413.

PMID: 38759134 PMC: 11175636. DOI: 10.1212/WNL.0000000000209413.


Explanatory Capacity of Postural Control and Physical Fitness in Cognitive Impairment and Support Needs among Individuals with Intellectual Disabilities-A Cross-Sectional Pilot Study.

Reguera-Garcia M, Fernandez-Baro E, Diez-Vega I, Varona-Echave I, Seco-Calvo J Brain Sci. 2023; 13(8).

PMID: 37626569 PMC: 10452408. DOI: 10.3390/brainsci13081213.


Cognitive outcome measures for tracking Alzheimer's disease in Down syndrome.

Fleming V, Hom C, Clare I, Hurd-Thomas S, Krinsky-McHale S, Handen B Int Rev Res Dev Disabil. 2023; 62:227-263.

PMID: 37396708 PMC: 10312212. DOI: 10.1016/bs.irrdd.2022.05.006.


Group cognitive stimulation therapy versus usual care for people with intellectual disabilities and dementia (CST-IDD) in the UK: protocol for a mixed-methods feasibility randomised controlled trial.

Ali A, Aguirre E, Carter J, Hoare S, Brackley K, Goulden N BMJ Open. 2023; 13(4):e072391.

PMID: 37116994 PMC: 10151918. DOI: 10.1136/bmjopen-2023-072391.